| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Departments of Neurology, Odense (Drs. Sindrup and Madsen) and Aarhus (Drs. Bach and Jensen) University Hospitals, and Clinical Pharmacology (Dr. Gram), University of Southern Denmark, Odense.
Address correspondence and reprint requests to Søren H. Sindrup, MD, Department of Neurology, Odense University Hospital, DK-5000 Odense C, Denmark; e-mail: s.sindrup{at}dadlnet.dk
Background: Tricyclic antidepressants (TCA) are often used in the treatment of painful polyneuropathy. Venlafaxine is a serotonin and weak noradrenaline reuptake inhibitor antidepressant with a different profile of other pharmacologic actions from those of TCA.
Objective: To test if venlafaxine would relieve painful polyneuropathy and compare its possible efficacy with that of the TCA imipramine.
Methods: The study design was randomized, double blind, and placebo controlled, with a three-way crossover. Forty patients were assigned to one of the treatment sequences, and 29 completed all three study periods. The daily doses were venlafaxine 225 mg and imipramine 150 mg. During the three treatment periods, each of 4 weeks’ duration, patients rated pain paroxysms, constant pain, and touch- and pressure-evoked pain by use of 0- to 10-point numeric rating scales.
Results: The sum of the individual pain scores during treatment week 4 was lower on venlafaxine (80% of baseline score; p = 0.006) and imipramine (77%; p = 0.001) than on placebo (100%) and did not show any statistical difference between venlafaxine and imipramine (p = 0.44). The individual pain scores for pain paroxysms, constant pain, and pressure-evoked pain showed a similar pattern, whereas touch-evoked pain was uncommon and was not altered by any of the drugs. Numbers needed to treat to obtain one patient with moderate or better pain relief were 5.2 for venlafaxine and 2.7 for imipramine.
Conclusion: Venlafaxine relieves pain in polyneuropathy and may be as effective as imipramine.
This article has been cited by other articles:
|
|
 |
|
  J. F. Karp and C. F. Reynolds III Depression, Pain, and Aging Focus, January 1, 2009; 7(1): 17 - 27. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. J. Scrivani, D. A. Keith, and L. B. Kaban Temporomandibular Disorders N. Engl. J. Med., December 18, 2008; 359(25): 2693 - 2705. [Full Text] [PDF]
|
|
|
|
 |
|
 L. Guilherme Soares and V. W. Chan Review Article: The Rationale for a Multimodal Approach in the Management of Breakthrough Cancer Pain: A Review American Journal of Hospice and Palliative Medicine, November 1, 2007; 24(5): 430 - 439. [Abstract] [PDF]
|
|
|
|
 |
|
 Z. T. Bloomgarden Diabetic Retinopathy and Diabetic Neuropathy Diabetes Care, March 1, 2007; 30(3): 760 - 765. [Full Text] [PDF]
|
|
|
|
 |
|
 M. M. Huizinga and A. Peltier Painful Diabetic Neuropathy: A Management-Centered Review Clin. Diabetes, January 1, 2007; 25(1): 6 - 15. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Sharp and B. Keefe Psychiatry in Chronic Pain: A Review and Update Focus, September 1, 2006; 4(4): 573. [Full Text] [PDF]
|
|
|
|
 |
|
 T. S Jensen, M.-M. Backonja, S. H. Jimenez, S. Tesfaye, P. Valensi, and D. Ziegler New perspectives on the management of diabetic peripheral neuropathic pain Diabetes and Vascular Disease Research, September 1, 2006; 3(2): 108 - 119. [Abstract] [PDF]
|
|
|
|
 |
|
 I. Gilron, C. P. N. Watson, C. M. Cahill, and D. E. Moulin Neuropathic pain: a practical guide for the clinician. Can. Med. Assoc. J., August 1, 2006; 175(3): 265 - 275. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Argoff, M.-M. Backonja, M. J. Belgrade, G. J. Bennett, M. R. Clark, B. E. Cole, D. A. Fishbain, G. A. Irving, B. H. McCarberg, and M. J. McLean Consensus Guidelines: Treatment Planning and Options Mayo Clin. Proc., April 1, 2006; 81(4_Suppl): S12 - S25. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. E. Miller, S. M. Adams, and M. M. Miller Antidepressant medication use in palliative care American Journal of Hospice and Palliative Medicine, March 1, 2006; 23(2): 127 - 133. [Abstract] [PDF]
|
|
|
|
 |
|
 R. H. Dworkin and J. T. Farrar Research design issues in pain clinical trials Neurology, December 29, 2005; 65(12_suppl_4): S1 - S2. [Full Text] [PDF]
|
|
|
|
|
|
G. A. Irving Contemporary assessment and management of neuropathic pain Neurology, June 28, 2005; 64(12_suppl_3): S21 - S27. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Chen, T. J. Lamer, R. H. Rho, K. A. Marshall, B. T. Sitzman, S. M. Ghazi, and R. P. Brewer Contemporary Management of Neuropathic Pain for the Primary Care Physician Mayo Clin. Proc., December 1, 2004; 79(12): 1533 - 1545. [Abstract] [PDF]
|
|
|
|
 |
|
 D. Lussier, A. G. Huskey, and R. K. Portenoy Adjuvant Analgesics in Cancer Pain Management Oncologist, September 1, 2004; 9(5): 571 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Otto, F. W. Bach, T. S. Jensen, and S. H. Sindrup Valproic acid has no effect on pain in polyneuropathy: A randomized, controlled trial Neurology, January 27, 2004; 62(2): 285 - 288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. H. Dworkin, M. Backonja, M. C. Rowbotham, R. R. Allen, C. R. Argoff, G. J. Bennett, M. C. Bushnell, J. T. Farrar, B. S. Galer, J. A. Haythornthwaite, et al. Advances in Neuropathic Pain: Diagnosis, Mechanisms, and Treatment Recommendations Arch Neurol, November 1, 2003; 60(11): 1524 - 1534. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Minerva BMJ, May 3, 2003; 326(7396): 992 - 992. [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
